EA202190887A1 - Фотозащитные композиции, содержащие полученные из malassezia соединения, и/или их химические аналоги - Google Patents

Фотозащитные композиции, содержащие полученные из malassezia соединения, и/или их химические аналоги

Info

Publication number
EA202190887A1
EA202190887A1 EA202190887A EA202190887A EA202190887A1 EA 202190887 A1 EA202190887 A1 EA 202190887A1 EA 202190887 A EA202190887 A EA 202190887A EA 202190887 A EA202190887 A EA 202190887A EA 202190887 A1 EA202190887 A1 EA 202190887A1
Authority
EA
Eurasian Patent Office
Prior art keywords
malassezia
compounds
compositions containing
containing compounds
compounds obtained
Prior art date
Application number
EA202190887A
Other languages
English (en)
Inventor
Майкл Айнцигер
Энн Мари Симпсон
Original Assignee
Майкл Айнцигер
Энн Мари Симпсон
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Майкл Айнцигер, Энн Мари Симпсон filed Critical Майкл Айнцигер
Publication of EA202190887A1 publication Critical patent/EA202190887A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Toxicology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Соединения, композиции и способы модулирования пигментации кожи и лечения или предупреждения у субъекта УФ-индуцированного повреждения кожи, эритемы, старения кожи, солнечного ожога и гиперпигментации. Соединения, полученные из Malassezia, и/или их химические аналоги, композиции, которые содержат такие соединения, и способы лечения путем введения соединений и композиций, включая способы индукции апоптоза меланоцитов и модулирование активности рецепторов ароматических углеводородов (AhR), меланогенеза и концентрации меланина.
EA202190887A 2018-10-08 2019-10-08 Фотозащитные композиции, содержащие полученные из malassezia соединения, и/или их химические аналоги EA202190887A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862742657P 2018-10-08 2018-10-08
PCT/US2019/055239 WO2020076857A1 (en) 2018-10-08 2019-10-08 Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Publications (1)

Publication Number Publication Date
EA202190887A1 true EA202190887A1 (ru) 2021-07-12

Family

ID=68345050

Family Applications (5)

Application Number Title Priority Date Filing Date
EA202092467A EA202092467A1 (ru) 2018-10-08 2019-04-12 Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги
EA202092655A EA202092655A1 (ru) 2018-10-08 2019-05-07 Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги
EA202190044A EA202190044A1 (ru) 2018-10-08 2019-06-14 Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги
EA202190566A EA202190566A1 (ru) 2018-10-08 2019-08-23 Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги
EA202190887A EA202190887A1 (ru) 2018-10-08 2019-10-08 Фотозащитные композиции, содержащие полученные из malassezia соединения, и/или их химические аналоги

Family Applications Before (4)

Application Number Title Priority Date Filing Date
EA202092467A EA202092467A1 (ru) 2018-10-08 2019-04-12 Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги
EA202092655A EA202092655A1 (ru) 2018-10-08 2019-05-07 Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги
EA202190044A EA202190044A1 (ru) 2018-10-08 2019-06-14 Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги
EA202190566A EA202190566A1 (ru) 2018-10-08 2019-08-23 Фотозащитные композиции, содержащие полученные из malassezia соединения и/или их химические аналоги

Country Status (15)

Country Link
US (1) US20200276100A1 (ru)
EP (1) EP3864019A1 (ru)
JP (1) JP2022508655A (ru)
KR (1) KR20210072062A (ru)
CN (1) CN113195495A (ru)
AU (1) AU2019357469A1 (ru)
BR (1) BR112021006658A2 (ru)
CA (1) CA3115647A1 (ru)
EA (5) EA202092467A1 (ru)
IL (1) IL282196A (ru)
MX (1) MX2021004033A (ru)
PH (1) PH12021550746A1 (ru)
SG (1) SG11202103599YA (ru)
TW (1) TW202034913A (ru)
WO (1) WO2020076857A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023064486A1 (en) * 2021-10-14 2023-04-20 Galileo Biosystems, Inc. Aryl hydrocarbon receptor (ahr) modulators and therapeutic uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6669944B2 (en) 2001-04-03 2003-12-30 Counsel Of Scientific & Industrial Research Process for the preparation of an extract with carotenoids, UV absorption, antibacterial and pH indicating properties from a deep-sea bacterium
US9969686B2 (en) * 2014-08-05 2018-05-15 Wisconsin Alumni Research Foundation Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them
CN109311884B (zh) * 2016-03-10 2021-09-14 M·因泽格 作为皮肤增白剂的马拉色因及其类似物
SG11202010077TA (en) * 2018-04-12 2020-11-27 Michael Einziger Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof

Also Published As

Publication number Publication date
EA202190566A1 (ru) 2021-06-02
EA202190044A1 (ru) 2021-03-29
PH12021550746A1 (en) 2021-10-04
US20200276100A1 (en) 2020-09-03
EA202092655A1 (ru) 2021-02-25
TW202034913A (zh) 2020-10-01
CN113195495A (zh) 2021-07-30
SG11202103599YA (en) 2021-05-28
AU2019357469A1 (en) 2021-05-13
KR20210072062A (ko) 2021-06-16
EA202092467A1 (ru) 2021-02-12
EP3864019A1 (en) 2021-08-18
IL282196A (en) 2021-05-31
JP2022508655A (ja) 2022-01-19
CA3115647A1 (en) 2020-04-16
WO2020076857A1 (en) 2020-04-16
MX2021004033A (es) 2021-09-10
BR112021006658A2 (pt) 2021-08-31

Similar Documents

Publication Publication Date Title
PH12020551677A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
ECSP13013068A (es) Halogenoalquil-1,3-oxazinas como inhibidores de la bace1 y/o bace2
PH12021550315A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
BR112018071183A2 (pt) derivados de bisfenol e seu uso como moduladores de atividade de receptor de androgênio
PE20161035A1 (es) Compuestos y usos de estos para la modulacion de la hemoglobina
NO20072199L (no) Trombopoietinaktivitetsmodulerende forbindelser og fremgangsmater
ECSP23067156A (es) Compuesto de quinazolina para inducir la degradación de la proteína kras mutante g12d
PH12020551845A1 (en) Photoprotective compositions containing malassezia-derived compounds and/or chemical analogs thereof
EA201891377A1 (ru) ПРИМЕНЕНИЕ МОДУЛЯТОРОВ КАНАЛОВ Kv3.1/Kv3.2/Kv3.3 ДЛЯ ЛЕЧЕНИЯ БОЛИ
EA202190887A1 (ru) Фотозащитные композиции, содержащие полученные из malassezia соединения, и/или их химические аналоги
CO2022002781A2 (es) Receptores agonistas no peptídicos de somatostatina tipo 5 y usos de los mismos
BR112018068293A2 (pt) malassezina e seus análogos como agentes de clareamento de pele
EA201690591A1 (ru) Композиция для осветления кожи
MX2020013690A (es) Composiciones fotoprotectoras que contienen compuestos derivados de malassezia y/o análogos químicos de los mismos.
PH12019502721A1 (en) Botulinum neurotoxin for treatment of disorders associated with melanocyte hyperactivity and/or excess melanin
EA201890886A1 (ru) Композиция для отбеливания кожи
MX2022003140A (es) Composicion para aclarar la piel.
CL2021001656A1 (es) Compuestos de imidazopiridina e imidazopiridina y sus usos.
BR112015017289A8 (pt) composição cosmética, processos cosméticos não terapêuticos para cuidado e/ou maquilagem de uma matéria queratínica, para limitar o escurecimento da pele e para prevenir e/ou tratar os sinais de envelhecimento e usos de uma composição cosmética
BR112015017119A8 (pt) composição cosmética, processos cosméticos não terapêuticos para cuidado e/ou maquilagem de uma matéria queratínica, para limitar o escurecimento da pele e para evitar e/ou tratar os sinais de envelhecimento e usos de uma composição cosmética
EA201791493A1 (ru) Композиция для отбеливания кожи, содержащая ниацинамид и иломастат
EA202190798A1 (ru) Ротамерные изомеры 4-алкил-5-гетероарил-3h-1,2-дитиол-3-тионов
MX2020009271A (es) Composiciones y métodos para el tratamiento de la resistencia a la insulina.
DOP2013000004A (es) Agentes terapeuticos 976
Winkie et al. A focused review of visible light therapies for vitiligo